These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
96 related items for PubMed ID: 9284199
1. The in vitro effect of vitamin D3 analogue EB-1089 on a human prostate cancer cell line (PC-3). Wang X, Chen X, Akhter J, Morris DL. Br J Urol; 1997 Aug; 80(2):260-2. PubMed ID: 9284199 [Abstract] [Full Text] [Related]
2. Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analogue EB 1089 in prostate cancer cells. Peehl DM, Seto E, Hsu JY, Feldman D. J Urol; 2002 Oct; 168(4 Pt 1):1583-8. PubMed ID: 12352462 [Abstract] [Full Text] [Related]
6. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells. Kubota T, Koshizuka K, Koike M, Uskokovic M, Miyoshi I, Koeffler HP. Cancer Res; 1998 Aug 01; 58(15):3370-5. PubMed ID: 9699668 [Abstract] [Full Text] [Related]
7. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system. Getzenberg RH, Light BW, Lapco PE, Konety BR, Nangia AK, Acierno JS, Dhir R, Shurin Z, Day RS, Trump DL, Johnson CS. Urology; 1997 Dec 01; 50(6):999-1006. PubMed ID: 9426741 [Abstract] [Full Text] [Related]
8. The G gamma / T-15 transgenic mouse model of androgen-independent prostate cancer: target cells of carcinogenesis and the effect of the vitamin D analogue EB 1089. Perez-Stable CM, Schwartz GG, Farinas A, Finegold M, Binderup L, Howard GA, Roos BA. Cancer Epidemiol Biomarkers Prev; 2002 Jun 01; 11(6):555-63. PubMed ID: 12050097 [Abstract] [Full Text] [Related]
10. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP. Anticancer Res; 1999 Jun 01; 19(3A):1689-97. PubMed ID: 10470102 [Abstract] [Full Text] [Related]
11. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells. Hisatake J, Kubota T, Hisatake Y, Uskokovic M, Tomoyasu S, Koeffler HP. Cancer Res; 1999 Aug 15; 59(16):4023-9. PubMed ID: 10463602 [Abstract] [Full Text] [Related]
15. Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells. Swamy N, Chen TC, Peleg S, Dhawan P, Christakos S, Stewart LV, Weigel NL, Mehta RG, Holick MF, Ray R. Clin Cancer Res; 2004 Dec 01; 10(23):8018-27. PubMed ID: 15585637 [Abstract] [Full Text] [Related]
17. Induction of apoptosis and inhibition of prostate and breast cancer growth by BGP-15, a new calcipotriene-derived vitamin D3 analog. Berkovich L, Ben-Shabat S, Sintov AC. Anticancer Drugs; 2010 Jul 01; 21(6):609-18. PubMed ID: 20335794 [Abstract] [Full Text] [Related]
18. Vitamin D3 analogue (EB 1089) inhibits in vitro cellular proliferation of human colon cancer cells. Akhter J, Goerdel M, Morris DL. Br J Surg; 1996 Feb 01; 83(2):229-30. PubMed ID: 8689173 [No Abstract] [Full Text] [Related]
19. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Díaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A. Cancer Res; 2000 Apr 15; 60(8):2304-12. PubMed ID: 10786699 [Abstract] [Full Text] [Related]